Abstract
A detailed patient-by-patient costing analysis, based on case records for 253 patients diagnosed in 1993, reveals that the mean 4-year diagnosis and management costs amounted to £6150 and £5668 for non-small cell and small cell lung cancer respectively. These costs are lower than those identified in Canadian studies, the difference being explained by the use of a simulated costing methodology in these studies, lower unit costs and less aggressive interventions.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Evans, W. K., Will, B. P., Bertholot, J-M & Wolfson, M. C. (1995a) The cost of managing lung cancer in Canada. Oncology 9: 147–153.
Evans, W. K., Will, B. P., Bertholot, J-M & Wolfson, M. C. (1995b) Diagnostic and therapeutic approaches to lung cancer in Canada and their costs. Br J Cancer 72: 1270–1277.
Evans, W. K., Will, B. P., Bertholot, J-M & Wolfson, M. C. (1996) The economics of lung cancer management in Canada. Lung Cancer 14: 19–29.
NHS Management Executive (1993). Costing for Contracts Manual. Department of Health: Leeds
Office of Health Economics (1997). Compendium of Health Statistics. OHE: London
Parsonage, M. & Neuberger, H. (1992) Discounting and health benefits. Health Economics 1: 71–76.
Rafuse, J. (1993) Study of lung cancer treatment costs may point to savings on a broader scale. J Can Med Assoc 149: 1162–1165.
Report of a meeting of physicians at the Royal Marsden Hospital U (1995) Small-cell lung cancer. Lancet 345: 1285–1289.
Standing Medical Advisory Committee (1994). Management of Lung Cancer: Current Clinical Practices. Department of Health: London
Virgo, K. S., Naunheim, K. S., McKirgan, L. W., Kissling, M. E., Lin, J. C. & Johnson, F. E. (1996) Cost of patient follow-up after potentially curative lung cancer treatment. J Thoracic Cardiovasc Surg 112: 356–363.
Whynes, D. K. & Walker, A. R. (1995) On approximations in treatment costing. Health Economics 4: 31–39.
Williams, C. (1992). Lung Cancer – the Facts. Oxford University Press: Oxford
Wolstenholme, J. L. & Whynes, D. K. (1998) Stage-specific treatment costs for cervical cancer in the United Kingdom. Eur J Cancer 34: 1889–1893.
Wolstenholme, J. L., Smith, S. J. & Whynes, D. K. (1998) The costs of treating breast cancer in the United Kingdom: implications for screening. Int J Technol Assessment Health Care 14: 277–289.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Wolstenholme, J., Whynes, D. The hospital costs of treating lung cancer in the United Kingdom. Br J Cancer 80, 215–218 (1999). https://doi.org/10.1038/sj.bjc.6690341
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690341
Keywords
This article is cited by
-
An analysis of the economic impact of smoking cessation in Europe
BMC Public Health (2013)
-
Le coût du traitement des cancers bronchopulmonaires non à petites cellules (CBNAPC)
Oncologie (2012)
-
Factors influencing hospital costs of lung cancer patients in Northern Ireland
The European Journal of Health Economics (2008)
-
Economics of the clinical management of lung cancer in France: an analysis using a Markov model
British Journal of Cancer (2004)
-
A cost-effectiveness analysis of a residential radon remediation programme in the United Kingdom
British Journal of Cancer (1999)
